Story display


ID:

526

Date:

2009-05-21

Headline:

Bad Bargain

Reporter's name:

Katherine Eban

Delay/denial:

No

Lawsuit:

No

Fees:

No

Media outlet:

Self (magazine)

City:

Washington, DC

Summary:

Self magazine used FOIA to obtain hundreds of pages of documents from the Food and Drug Administration (FDA) regarding the agency's troubled drug-manufacturing inspection schedule. One large manufacturer of generic medications, Ranbaxy Laboratories, delayed informing regulators of some problems and belatedly notified the FDA of others, but the issue is hardly limited: the agency seldom visits international plants, and certainly not with an element of surprise.

Keywords:

prescription, prescription drug, generics, generic drugs, pills, drug manufacturing, health, medicine, Food and Drug Administration, FDA, Ranbaxy, Wellbutrin XL, Budeprion XL

URL:

http://www.self.com/health/2009/06/dangers-of-generic-drugs?currentPage=1


Agencies:

FDA
GAO

States:

CA
DC
FL
GA
IL
MA
MD
MI
MN
MO
NC
NJ
NY
PA
TX

Categories:

drug safety
health care


Return to front page